[go: up one dir, main page]

DK1459751T3 - (S,S)reboxetin til behandling af migrænehovedpine - Google Patents

(S,S)reboxetin til behandling af migrænehovedpine

Info

Publication number
DK1459751T3
DK1459751T3 DK04013383T DK04013383T DK1459751T3 DK 1459751 T3 DK1459751 T3 DK 1459751T3 DK 04013383 T DK04013383 T DK 04013383T DK 04013383 T DK04013383 T DK 04013383T DK 1459751 T3 DK1459751 T3 DK 1459751T3
Authority
DK
Denmark
Prior art keywords
reboxetine
treatment
migraine headaches
headaches
migraine
Prior art date
Application number
DK04013383T
Other languages
English (en)
Inventor
Saeeduddin Ahmed
Lars Birgerson
Pasquale Cetera
Robert Clyde Marshall
Robert Mcarthur
Duncan P Taylor
Erik H F Wong
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32831120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1459751(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Priority claimed from EP00941659A external-priority patent/EP1196172B1/en
Application granted granted Critical
Publication of DK1459751T3 publication Critical patent/DK1459751T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04013383T 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine DK1459751T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14196899P 1999-07-01 1999-07-01
US14413199P 1999-07-16 1999-07-16
US15825699P 1999-10-06 1999-10-06
US17038199P 1999-12-13 1999-12-13
EP00941659A EP1196172B1 (en) 1999-07-01 2000-06-22 (S,S)-Reboxetine for treating chronic pain

Publications (1)

Publication Number Publication Date
DK1459751T3 true DK1459751T3 (da) 2005-12-19

Family

ID=32831120

Family Applications (5)

Application Number Title Priority Date Filing Date
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner

Country Status (3)

Country Link
EP (10) EP1459750B1 (da)
DK (5) DK1493442T3 (da)
SI (1) SI1196172T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1763354A2 (en) * 2004-06-09 2007-03-21 Pfizer Limited Use of reboxetine for the treatment of pain
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
AU9214498A (en) * 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
CN1301164A (zh) * 1998-04-09 2001-06-27 法玛西雅厄普约翰美国公司 神经病症的新疗法
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
BR9909559A (pt) * 1998-05-08 2000-12-19 Upjohn Co Novas combinações de drogas
SK20012000A3 (sk) * 1998-06-29 2001-08-06 Pharmaceuticals Applications Asociates, Llc Transdermálny prostriedok na zmiernenie bolesti
SE9904750D0 (sv) * 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
CN1396829A (zh) * 2000-02-24 2003-02-12 法玛西雅厄普约翰美国公司 新的药物联合形式

Also Published As

Publication number Publication date
SI1196172T1 (sl) 2006-06-30
EP1459750B1 (en) 2005-06-01
EP1459751B1 (en) 2005-09-14
EP1632235A3 (en) 2006-06-14
DK1493442T3 (da) 2005-12-19
EP1632235A2 (en) 2006-03-08
DK1459748T3 (da) 2005-07-04
EP1493442B1 (en) 2005-09-28
EP1459749A1 (en) 2004-09-22
EP1459749B1 (en) 2005-10-05
DK1500396T3 (da) 2005-12-19
EP1632234A3 (en) 2006-03-15
EP1459748B8 (en) 2005-06-08
EP1629843A2 (en) 2006-03-01
EP1459748B1 (en) 2005-04-13
EP1500395A1 (en) 2005-01-26
EP1629843A3 (en) 2006-03-15
EP1500396B1 (en) 2005-09-28
EP1500396A1 (en) 2005-01-26
EP1459751A1 (en) 2004-09-22
EP1632234A2 (en) 2006-03-08
DK1500395T3 (da) 2006-06-19
EP1500395B1 (en) 2006-03-08
EP1493442A1 (en) 2005-01-05
EP1459748A1 (en) 2004-09-22
EP1459750A1 (en) 2004-09-22
EP1632234B1 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK2412368T3 (da) Sammensætning til behandling af ar
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
NO20001870D0 (no) Ny fremgangsmõte for behandling
AU2001272852A1 (en) Composition for the treatment of migraine
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
EP1442062A4 (en) METHOD FOR TREATING CARCINOMA
NL1021504A1 (nl) Waterstofbehandelingsproces.
DE60227963D1 (de) Behandlungssystem
NO20024439L (no) Polymert, akrylamidfritt middel for tilbakeholdelse av vann
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1459751T3 (da) (S,S)reboxetin til behandling af migrænehovedpine
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
DK1451177T3 (da) Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne
MXPA03006970A (es) Nuevo uso de iloperidona.
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
DK1144382T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 1,5-diarylpyrazoler
IT1320200B1 (it) Lettino ortopedico, particolarmente per il trattamento di lombalgiederivanti da iperlordosi.